Companies / OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc.
Nasdaq: OKURCIK 1637715BOULDER, CO
Financials · FY2024
Ownership
40.5M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 0.15% | 59,226 |
| 10%+ / strategic | 1.55% | 626,593 |
| Institutions | 47.92% | 19,406,550 |
| Public float | 50.38% | 20,403,940 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Manke IsaacDirector | 0.05% | 20,583 |
Leverone Jason A.Chief Financial Officer | 0.04% | 16,000 |
Mathers Edward TDirector | 0.04% | 15,310 |
Saccomano Nicholas ACEOPresident and CEO · Director | 0.02% | 7,333 |
Access Industries Holdings LLC10% owner | — | — |
Access Industries Management, LLC10% owner | — | — |
AI Biotechnology LLC10% owner | — | — |
Blavatnik Len10% owner | — | — |
Grey Michael GDirector | — | — |
Institutional holders 50
View all →| Holder | Value | % of shares |
|---|---|---|
| $16.55M | 9.87% | |
| $8.24M | 7.01% | |
| $8.19M | 4.89% | |
| $6.84M | 3.70% | |
| $4.99M | 2.98% | |
| $2.94M | 2.50% | |
| $2.37M | 2.02% | |
| $2.26M | 1.93% | |
| $2.12M | 1.80% | |
| $2.11M | 1.14% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | RA Capital Management, L.P. 13F manager | New | Common stock | $16.55M | +4.0M | 3,998,333 9.87% of shares | medium |
| Q1 2026 as of | Bvf INC/IL 13F manager | New | Common stock | $8.19M | +2.0M | 1,978,972 4.89% of shares | medium |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $6.60M | +1.4M +2747.19% | 1,499,845 3.70% of shares | medium |
| Q1 2026 as of | Adage Capital Partners Gp, L.L.C. 13F manager | New | Common stock | $4.99M | +1.2M | 1,204,819 2.98% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | New | Common stock | $2.11M | +464K | 463,662 1.14% of shares | low |
| Q1 2026 as of | Cantor Fitzgerald, L. P. 13F manager | Trim | Common stock | $-1.43M | -345K -77.55% | 99,900 0.25% of shares | low |
| Q1 2026 as of | Renaissance Technologies LLC 13F manager | Add | Common stock | $537.8K | +130K +52.52% | 377,250 0.93% of shares | low |
| Q1 2026 as of | Marshall Wace, LLP 13F manager | New | Common stock | $150.9K | +36K | 36,444 0.09% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Citadel Advisors LLC | Passive13G/A | — |
| Highbridge Capital Management, LLC | Passive13G/A | — |
| ADAR1 Capital Management, LLC | Passive13G | — |
| RA Capital Management, L.P. | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| OKUR | — | 68277Q105 |